Retatrutide is an investigational once-weekly injectable medication that simultaneously activates three hormonal receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Side effect tolerance: Both injections may cause temporary GI discomfort, and each person responds differently
Keep a symptom diary noting headache frequency, duration, severity (110 scale), and any triggers like caffeine, sleep disruption, or stressthis information helps PlexusDx clinicians optimize your treatment plan
Investigated in structured metabolic research settings involving type-2 diabetes and obesity biomarker evaluation
A convenient format to support routine nutritionprotein and creatine support without mixing, designed for consistent use within structured programs and repeatable daily schedules
20 , e564e572 (2022)